Se-Se-PEG-PSMA-617
Diselenide-PEG-PSMA-617
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-M2-10027 | 5mg | 1399.00 | + Add to cart |
|
| R-M2-10027 | 10mg | 2595.00 | + Add to cart |
|
|
||||
Product description
The design of Se-Se-PEG-PSMA-617 may aim to utilize the redox sensitivity of selenium selenium bonds to achieve controlled release or activation of drugs in specific environments, such as the tumor microenvironment.
This type of molecule may be used for:
Prodrug design: Local activation of PSMA-617 is achieved by breaking the Se Se bond, improving the treatment window.
Responsive delivery: Combining PSMA targeting with redox responsiveness to achieve tumor specific drug release.
| Appearance | N/A |
|---|---|
| Molecular weight | N/A |
| PEG Molecular weight | N/A |
| Solubility | N/A |
| Molecular formula | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 1-3 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of Se-Se-PEG-PSMA-617
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


